As bioconjugation expands beyond conventional antibody-drug conjugates into oligonucleotide, peptide, and other complex formats, process development, analytics, and GMP manufacturing need to stay aligned.
In this on-demand webinar, Jaeook James Kim, Ph.D., Associate Director of Bioconjugation Development at Samsung Biologics, shares how integrated development, manufacturing, analytical, and formulation capabilities at a single site support complex bioconjugation programs. The session covers experience across multiple conjugation technologies and a case example of process scale-up and transfer from laboratory development to GMP manufacturing.
Key highlights include:
Integrated development and manufacturing for cytotoxic and non-cytotoxic bioconjugates at a single site
Process scale-up from laboratory development to pilot and GMP manufacturing
Analytical, formulation, and CMC considerations across development
Discover how a single-site model can support a more seamless path from development to GMP manufacturing.
As bioconjugation expands beyond conventional antibody-drug conjugates into oligonucleotide, peptide, and other complex formats, process development, analytics, and GMP manufacturing need to stay aligned.
In this on-demand webinar, Jaeook James Kim, Ph.D., Associate Director of Bioconjugation Development at Samsung Biologics, shares how integrated development, manufacturing, analytical, and formulation capabilities at a single site support complex bioconjugation programs. The session covers experience across multiple conjugation technologies and a case example of process scale-up and transfer from laboratory development to GMP manufacturing.
Key highlights include:
Integrated development and manufacturing for cytotoxic and non-cytotoxic bioconjugates at a single site
Process scale-up from laboratory development to pilot and GMP manufacturing
Analytical, formulation, and CMC considerations across development
Discover how a single-site model can support a more seamless path from development to GMP manufacturing.
Related Content